School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Tokyo 192-0392, Japan.
Research Center for Medicinal Plant Resources, National Institutes of Biomedical Innovation, Health and Nutrition, Tsukuba 305-0843, Japan.
Molecules. 2022 May 3;27(9):2909. doi: 10.3390/molecules27092909.
Retusone A (), a new sesquiterpene dimer consisting of two guaiane-type sesquiterpenoids, and oleodaphnal () were isolated from heartwood of (Thymelaeaceae). The planar structure of was elucidated on the basis of HRESIMS and NMR spectroscopic data, and the relative stereochemistry was established by X-ray diffraction analysis. The absolute configuration of was determined by electronic circular dichroism. Compound suppressed luciferase reporter gene expression driven by the HBO1 (histone acetyltransferase binding to ORC1) gene promoter in human breast cancer MCF7 cells. Compound also decreased the expression of endogenous HBO1 mRNA and protein, and inhibited proliferation of the cells. These results suggest that retusone A (), which has a unique dimeric sesquiterpenoid structure with inhibitory activity against HBO1 expression, may contribute to the development of a novel therapeutic candidate for the treatment of breast cancer.
瑞妥酮 A(),一种由两个愈创木烷型倍半萜组成的新倍半萜二聚体,以及油桐素()从(卫矛科)心材中分离得到。根据高分辨质谱和 NMR 波谱数据阐明了 的平面结构,并通过 X 射线衍射分析确定了其相对立体化学构型。通过电子圆二色谱确定了 的绝对构型。化合物 抑制人乳腺癌 MCF7 细胞中 HBO1(组蛋白乙酰转移酶结合 ORC1)基因启动子驱动的荧光素酶报告基因表达。化合物 还降低了内源性 HBO1 mRNA 和蛋白的表达,并抑制了细胞的增殖。这些结果表明,具有抑制 HBO1 表达活性的独特二聚倍半萜结构的瑞妥酮 A()可能有助于开发治疗乳腺癌的新型治疗候选药物。